Showing 31-40 of 1698 results for "".
Safety Monitoring of Disease-Modifying Therapies in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/safety-monitoring-of-disease-modifying-therapies-in-multiple-sclerosis/31262/Aisha Elfasi, MD, Clinical and Research Fellow, Department of Neurology, Johns Hopkins University, provides an overview of the currently available disease-modifying therapies for multiple sclerosis, highlighting important safety considerations and routine monitoring requirements.The Role of Advanced Genomic Testing in the Diagnosis and Treatment of Neurologic Conditions
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/the-role-of-advanced-genomic-testing-in-the-diagnosis-and-treatment-of-neurologic-conditions/30100/Paul Kruszka, MD, Chief Medical Officer at GeneDx, discusses advanced genomic testing, emphasizing how these tests are used to guide diagnosis and treatment decisions associated with neurodevelopmental conditions, including genetic variants associated with epilepsy.Ocrevus Treatment in Pregnant and Lactating Women with Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/ocrevus-treatment-pregnant-lactating-women-with-multiple-sclerosis/35558/Riley Bove, MD, UCSF School of Medicine, San Francisco, CA details results from the MINORE and SOPRANINO studies examining Ocrevus treatment in pregnant and lactating women with multiple sclerosis.SMA Experience: Episode 1
https://practicalneurology.com/diseases-diagnoses/neuromuscular/sma-experiences/30080/Neuromuscular disease expert Charlotte Sumner, MD chats with her patient Nicole Moore about some of her life goals and how recent treatment options have changed the conversations between them.RENEU (A Study to Evaluate the Safety, Effectiveness, and Tolerability of Gomekli in Children Aged ≥2 Years and Adults with an Inoperable NF1-PN; NCT03962543)
https://practicalneurology.com/diseases-diagnoses/neuro-oncology/trials-in-2/35433/Christopher Moertel, MD, Medical Director of the Pediatric Neuro-Oncology and Neurofibromatosis Programs at the University of Minnesota provides an overview of the ReNeu clinical trial which evaluated the safety, effectiveness, and tolerability of Gomekli in children aged ≥2 years and adults.About the Cover Artist
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/audrius-v-plioplys-md-is-a-neurologist-who-has-merged-the-research-lab-with-the-art-studio/31667/Audrius V. Plioplys, MD, is a neurologist who has merged the research lab with the art studio.Rett Syndrome: Magnolia and Her Family's Experience
https://practicalneurology.com/diseases-diagnoses/movement-disorders/rett-syndrome-magnolia-and-her-familys-experience/30097/AJ Tesler shares the story of his daughter, Magnolia, who is living with Rett syndrome. As a parent and caregiver, AJ provides his perspective throughout the diagnostic and therapeutic journey for Rett syndrome and is joined by Rett syndrome expert Carey Fu, MD, Pediatric Neurologist at Vanderbilt UThe Importance of Early Diagnosis and Treatment of Alzheimer Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/the-importance-of-early-diagnosis-and-treatment-of-alzheimer-disease/35436/Linda Shows, a semi-retired nurse who lives with mild cognitive impairment, and her physician, Wendell Helveston, MD, Hattiesburg Clinic, Hattiesburg, MS, discuss the importance of early diagnosis and treatment in Alzheimer disease, including other factors that can help patients thrive when living wSMA Experience: Episode 2
https://practicalneurology.com/diseases-diagnoses/neuromuscular/sma-experience-episode-2/30081/Neuromusclar disease expert Diana Bharucha-Goebel, MD, PhD chats with Traci High, mother of two patients with SMA about how the SMA treatment landscape, and her childens' lives, have changed over the past 15 years.Biomarker Testing Modalities for Alzheimer Disease
https://practicalneurology.com/videos/neurology-in-motion/biomarker-testing-modalities-for-alzheimer-disease/35432/Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses key factors physicians should consider when ordering a biomarker test and recommendations for how physicians should communicate the need for a particular test with their p